/ /

  • linkedin
  • Increase Font
  • Sharebar

    Better alternatives to standalone prostaglandin analog therapy

    Physicians have the option of various adjunctive therapy when prostaglandin analog therapy alone is not sufficiently potent to lower IOP, i.e., they can add one agent, a fixed-combination therapy, or perform selective laser trabeculoplasty (SLT).

    “We need to add a second-line agent when the target IOP is not achieved or the target has to be reset when pressure is not lowered enough and progression of glaucoma at the current IOP is noted,” said Sanjay G. Asrani, MD.

    But there are a number of considerations surrounding addition of a second-line agent: patient compliance, side effects, allergic reactions, contraindications, and call backs.

    Dr. Asrani sets the target IOP range according to the guidelines of the Canadian Society.

    Slideshow: Photoactivation holds promise for keratitis treatment

    Specifically, for patients with advanced glaucoma, the target is in the low teens with the least fluctuation tolerance, i.e., less than 3 mm Hg; for moderate glaucoma, the target range is the mid-teens with acceptable fluctuations of less than 4 mm Hg; and for mild glaucoma, the target range is the high teens with acceptable fluctuations of less than 5 mm Hg, he outlined.

    Dr. Asrani, professor of ophthalmology; Head, Glaucoma OCT Reading Center; and director, Duke Eye Center of Cary, Duke University, Durham, NC, enumerated some important considerations.

    Related: Cataract surgery cuts glaucoma risk in eyes with pseudoexfoliation

    He noted that roughly a third of patients who are newly treated require adjunctive therapy within one year. When the adjunctive therapy is combined with a prostaglandin, the patients are typically instilling drops twice daily, once in the morning and again in the evening.

    When a single drug agent is added, the mean IOP-lowering effect is similar, but the side effects and nocturnal IOP-lowering efficacy differ.

    Side effects

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results